Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
Clinical trial NCT00068952 · COMPLETED
Trial details
- NCT number
- NCT00068952
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.